« Previous
Next »
Titles
- M4 organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use1
- M4E(R2): the CTD--efficacy1
- M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk1
- Manufacturers sharing patient-specific information from medical devices with patients upon request: guidance for industry and Food and Drug Administration staff1
- Marketing clearance of diagnostic ultrasound systems and transducers: guidance for industry and Food and Drug Administration staff1
- Marketing status notifications under Section 506I of the Federal Food, Drug, and Cosmetic Act: content and format1
- Maximal usage trials for topically applied active ingredients being considered for inclusion in an over-the -counter monograph: study elements and considerations1
- Medicaid Fraud Control Units fiscal year 2016 annual report1
- Medicaid Fraud Control Units fiscal year 2017 annual report1
- Medicaid Fraud Control Units: investigation and prosecution of fraud and beneficiary abuse in Medicaid personal care services1
- Medicaid demonstrations: federal action needed to improve oversight of spending : report to the Chairman, Committee on Finance, U.S. Senate1
- Medicaid eligibility, enrollment, and renewal processes and system study: case study summary report--New York1
- Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Arizona1
- Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Colorado1
- Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Florida1
- Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Idaho1
- Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--North Carolina1
- Medicaid expansion waivers: what will we learn?1
- Medicaid personal care services: more harmonized program requirements and better data are needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1
- Medicaid program integrity: CMS should build on current oversight efforts by further enhancing collaboration with states : report to the Chairman, Committee on Finance, U.S. Senate1